Management of hypercalcaemia of malignancy in neuroendocrine tumour patients – A case series

#4634

Introduction: Hypercalcaemia of malignancy (HM) rarely coexists with neuroendocrine tumours (NET). There are no precise guidelines for management of hypercalcaemia in NET.

Aim(s): Our aim was to summarise the experience of our department in this area.

Materials and methods: We performed a retrospective chart review of our patients with NET and HM.

Conference:

Presenting Author:

Authors: Klepinowska M, Sagan K, Brzeska A, Andrysiak-Mamos E, Kiedrowicz B,

Keywords: hypercalcaemia of malignancy, neuroendocrine tumour, pancreatic neuroendocrine tumour, hypercalcaemia,